CoChat

Elevated plasma sVCAM‐1 levels in children with sickle cell disease: Impact of chronic transfusion therapy

Sakhalkar, Vishwas S., Rao, Sreedhar P., Weedon, Jeremy, Miller, Scott T. · 2004 · American Journal of Hematology
Cited by 41

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Vascular cell adhesion molecule‐1 (VCAM‐1) has been implicated as being important in the pathophysiology of acute pain episodes (APE) and acute chest syndrome (ACS) of sickle cell disease (SCD). The frequency of these episodes is reduced by chronic transfusion therapy. The impact of chronic transfusion therapy on VCAM‐1 expression is unknown. Soluble VCAM‐1 (sVCAM‐1) levels were measured in plasma using an ELISA assay (R&D Systems) in 61 patients with SCD (age range 1.5–20 years) and 12 normal controls (2.5–14 years). SCD patients included 20 with ACS, 14 with APE, 12 at well‐child visits, and 15 receiving chronic transfusion therapy. Asymptomatic SCD patients had higher sVCAM‐1 levels compared to normal subjects (P < 0.001). Levels of sVCAM‐1 were further elevated during ACS (P < 0.001) and APE (P = 0.072) and returned to the asymptomatic range on resolution. Levels were significantly lower in transfused patients (P = 0.003) compared to asymptomatic SCD patients. Our findings of increased VCAM‐1 expression during ACS and perhaps APE offer a rationale for therapeutic use of cytokine and other VCAM‐1 modulators. The reduction of sVCAM‐1 levels observed in our transfused SCD patients offers insight into the mechanism of the protective effect of transfusion against ACS and APE and possibly stroke. Am. J. Hematol. 76:57–60, 2004. © 2004 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ajh.20016

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 41

Metadata

Authors
Sakhalkar, V. S., Rao, S. P., Weedon, J., & Miller, S. T.
Venue
American Journal of Hematology
Publisher
Wiley
Published
2004-05
Volume
76
Issue
1
Pages
57-60
ISSN
  • 0361-8609 (ISSN-L)
  • 1096-8652
OpenAlex
W1990447822
Cited by
41
References
6
FWCI
1.02
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Elevated plasma sVCAM‐1 levels in children with sickle cell disease: Impact of chronic transfusion therapy. https://app.cochat.ai/papers/10.1002/ajh.20016
The paper
Sakhalkar, V. S., Rao, S. P., Weedon, J., & Miller, S. T. (2004). Elevated plasma sVCAM‐1 levels in children with sickle cell disease: Impact of chronic transfusion therapy. American Journal of Hematology. https://doi.org/10.1002/ajh.20016

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.